Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
Vande Casteele, Niels, Yang, Lili, Dobler, Iwona, Agboton, Christian, McRorie Osborn, Teresa, Suri, Ajit, Lindner, Dirk, Smithson, Glennda M
Published in Therapeutic drug monitoring (01.04.2023)
Published in Therapeutic drug monitoring (01.04.2023)
Get more information
Journal Article
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Pratz, Keith W, Kaplan, Jason, Levy, Moshe, Bixby, Dale, Burke, Patrick W, Erba, Harry, Wise-Draper, Trisha M, Roboz, Gail J, Papadantonakis, Nikolaos, Rajkhowa, Trivikram, Hernandez, Daniela, Dobler, Iwona, Gregory, Richard C, Li, Cheryl, Wang, Shining, Stumpo, Kate, Kannan, Karuppiah, Miao, Harry, Levis, Mark
Published in Haematologica (Roma) (01.03.2023)
Published in Haematologica (Roma) (01.03.2023)
Get full text
Journal Article
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
Kerbert, Annarein J.C., Gupta, Saurabh, Alabsawy, Eman, Dobler, Iwona, Lønsmann, Ida, Hall, Andrew, Nielsen, Signe Holm, Nielsen, Mette J., Gronbaek, Henning, Amoros, Àlex, Yeung, Dave, Macnaughtan, Jane, Mookerjee, Rajeshwar P., Macdonald, Stewart, Andreola, Fausto, Moreau, Richard, Arroyo, Vicente, Angeli, Paolo, Leeming, Diana J., Treem, William, Karsdal, Morten A., Jalan, Rajiv
Published in JHEP reports (01.12.2021)
Published in JHEP reports (01.12.2021)
Get full text
Journal Article
Safety, Tolerability, and Efficacy of Mezagitamab (TAK-079) as Add-On to Standard of Care Therapy in Individuals with Primary IgA Nephropathy: Interim Results from an Open-Label Phase 1b Study: FR-PO857
Barratt, Jonathan, Suzuki, Yusuke, Nguyen, Van Anh, Dobler, Iwona, Li, Cheryl, Farmer, MK
Published in Journal of the American Society of Nephrology (01.10.2024)
Published in Journal of the American Society of Nephrology (01.10.2024)
Get full text
Journal Article
675 Measuring Serum Vedolizumab and Antibodies to Vedolizumab: Comparison of Four Commercially Available Clinical Laboratory Assays to the Assay Used in Vedolizumab Development
Yang, Lili, Dobler, Iwona, Agboton, Christian, Osborn, Teresa, Smithson, Glennda
Published in The American journal of gastroenterology (01.10.2019)
Published in The American journal of gastroenterology (01.10.2019)
Get full text
Journal Article
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Swords, Ronan T., Coutre, Steven, Maris, Michael B., Zeidner, Joshua F., Foran, James M., Cruz, Jose, Erba, Harry P., Berdeja, Jesus G., Tam, Wayne, Vardhanabhuti, Saran, Pawlikowska-Dobler, Iwona, Faessel, Hélène M., Dash, Ajeeta B., Sedarati, Farhad, Dezube, Bruce J., Faller, Douglas V., Savona, Michael R.
Published in Blood (29.03.2018)
Published in Blood (29.03.2018)
Get full text
Journal Article
Comparative analytical performance of multiple plasma A beta 42 and A beta 40 assays and their ability to predict positron emission tomography amyloid positivity
Zicha, S., Bateman, R. J., Shaw, L. M., Zetterberg, Henrik, Bannon, A. W., Horton, W. A., Baratta, M., Kolb, H. C., Dobler, I., Mordashova, Y., Saad, Z. S., Raunig, D. L., Spanakis, E., Li, Y., Schindler, S. E., Ferber, K., Rubel, C. E., Martone, R. L., Weber, C. J., Edelmayer, R. M., Meyers, E. A., Bollinger, J. G., Rosenbaugh, E. G., Potter, W. Z., Alzheimer's Dis Neuroimaging, Initi, Alzheimer's Dis Project, Team
Published in Alzheimer's & dementia (01.03.2023)
Published in Alzheimer's & dementia (01.03.2023)
Get full text
Journal Article
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity
Zicha, Stephen, Bateman, Randall J., Shaw, Leslie M., Zetterberg, Henrik, Bannon, Anthony W., Horton, Wesley A., Baratta, Mike, Kolb, Hartmuth C., Dobler, Iwona, Mordashova, Yulia, Saad, Ziad S., Raunig, David L., Spanakis, Emmanouil (Manos), Li, Yan, Schindler, Suzanne E., Ferber, Kyle, Rubel, Carrie E., Martone, Robert L., Weber, Christopher J., Edelmayer, Rebecca M., Meyers, Emily A., Bollinger, James G., Rosenbaugh, Erin G., Potter, William Z.
Published in Alzheimer's & dementia (01.03.2023)
Published in Alzheimer's & dementia (01.03.2023)
Get full text
Journal Article
Developing Topics
Zicha, Stephen, Saad, Ziad S, Shaw, Leslie M, Bannon, Anthony W, Rubel, Carrie E, Schindler, Suzanne E, Dobler, Iwona, Du-Cuny, Lei, Giardina, Sarah F, Kolb, Hartmuth C, Meyers, Emily A, Mordashova, Yulia, Raunig, David L, Rosenbaugh, Erin G, Weber, Christopher J, Zhang, Hang, Zetterberg, Henrik, Potter, William Z
Published in Alzheimer's & dementia (01.12.2023)
Published in Alzheimer's & dementia (01.12.2023)
Get full text
Journal Article
Update to the comparative analytical performance of plasma Aβ assays and their relationship to amyloid PET
Zicha, Stephen, Saad, Ziad S., Shaw, Leslie M., Bannon, Anthony W., Rubel, Carrie E., Schindler, Suzanne E., Dobler, Iwona, Du‐Cuny, Lei, Giardina, Sarah F., Kolb, Hartmuth C., Meyers, Emily A., Mordashova, Yulia, Raunig, David L., Rosenbaugh, Erin G., Weber, Christopher J., Zhang, Hang, Zetterberg, Henrik, Potter, William Z.
Published in Alzheimer's & dementia (01.12.2023)
Published in Alzheimer's & dementia (01.12.2023)
Get full text
Journal Article
Comparative analytical performance of multiple plasma amyloid‐beta assays and their relationship to amyloid PET
Zicha, Stephen, Bateman, Randall J., Shaw, Leslie M., Bannon, Anthony W., Zetterberg, Henrik, Horton, Wesley A., Baratta, Michael, Kolb, Hartmuth C., Dobler, Iwona, Wang, Wenting, Raunig, David L., Saad, Ziad S., Mordashova, Yulia, Li, Yan, Bjorklund, Nicole L., Edelmayer, Rebecca M., Martone, Robert L., Rubel, Carrie E., Mawuenyega, Kwasi G., Bollinger, James G., Weber, Christopher J., Meyers, Emily A., Potter, William Z.
Published in Alzheimer's & dementia (01.12.2021)
Published in Alzheimer's & dementia (01.12.2021)
Get full text
Journal Article
Results of a Clinical Study of Pevonedistat (Pev), a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)
Swords, Ronan T, Coutre, Steven, Maris, Michael B., Zeidner, Joshua F., Foran, James M., Cruz, Jose C., Erba, Harry P., Berdeja, Jesus G., Tam, Wayne, Vardhanabhuti, Saran, Dobler, Iwona, Faessel, Hélène M., Dash, Ajeeta B., Sedarati, Farhad, Dezube, Bruce J., Savona, Michael R.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article